TWH-18657-53589
2 vaccinations
1 coded response
4 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 951 / CA
- Registered
- 2021-10-27
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-09-10
Dose 1 — Pfizer-BioNTech
-
2021-10-02
Dose 2 — Pfizer-BioNTech
-
2021-10-27
Registered in v-safe
- 2021-10-27
- 2021-11-01
- 2021-11-15
-
2022-01-01
Survey response — 3 months, dose 2MedDRA: Medical counselling, Myalgia, Nausea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Muscle aches, nausea · Healthcare visit (other): Advice nurseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-05
- 2022-01-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-10 | Pfizer-BioNTech | No |
| 2 | 2021-10-02 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — 3 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release